T0	Outcomes 141 175	chronic graft-versus-host disease.
T1	Outcomes 786 803	post-transplant).
T2	Outcomes 804 848	Median follow-up time for surviving patients
T3	Outcomes 1032 1127	lower National Institutes of Health Consensus moderate-severe chronic graft-versus-host disease
T4	Outcomes 1151 1191	and late acute graft-versus-host disease
T5	Outcomes 1255 1280	lower prednisone exposure
T6	Outcomes 1285 1322	earlier discontinuation of tacrolimus
T7	Outcomes 1435 1481	in complete immune suppression discontinuation